Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension

NCT00851929 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT00851929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00851929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
Lead sponsor
Medical University of South Carolina
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2008
Completion date
November 30, 2011
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, sarcoidosis